These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2849657)

  • 1. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
    Little PJ; Compton DR; Johnson MR; Melvin LS; Martin BR
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1046-51. PubMed ID: 2849657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
    Lichtman AH; Cook SA; Martin BR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):585-93. PubMed ID: 8632325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.
    Howlett AC; Johnson MR; Melvin LS; Milne GM
    Mol Pharmacol; 1988 Mar; 33(3):297-302. PubMed ID: 3352594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
    Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
    Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of indole- and pyrrole-derived cannabinoids.
    Wiley JL; Compton DR; Dai D; Lainton JA; Phillips M; Huffman JW; Martin BR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):995-1004. PubMed ID: 9618400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal and supraspinal components of cannabinoid-induced antinociception.
    Lichtman AH; Martin BR
    J Pharmacol Exp Ther; 1991 Aug; 258(2):517-23. PubMed ID: 1650831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
    Welch SP; Thomas C; Patrick GS
    J Pharmacol Exp Ther; 1995 Jan; 272(1):310-21. PubMed ID: 7815346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids.
    Martin BR; Compton DR; Little PJ; Martin TJ; Beardsley PM
    NIDA Res Monogr; 1987; 79():108-22. PubMed ID: 2830532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.
    Howlett AC; Fleming RM
    Mol Pharmacol; 1984 Nov; 26(3):532-8. PubMed ID: 6092901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.
    Järbe TU; Hiltunen AJ; Mathis DA; Hanŭs L; Breuer A; Mechoulam R
    J Pharmacol Exp Ther; 1993 Feb; 264(2):561-9. PubMed ID: 8382275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis: pharmacology and toxicology in animals and humans.
    Adams IB; Martin BR
    Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
    Melvin LS; Milne GM; Johnson MR; Subramaniam B; Wilken GH; Howlett AC
    Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
    Compton DR; Rice KC; De Costa BR; Razdan RK; Melvin LS; Johnson MR; Martin BR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):218-26. PubMed ID: 8474008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord.
    Pugh G; Mason DJ; Combs V; Welch SP
    J Pharmacol Exp Ther; 1997 May; 281(2):730-7. PubMed ID: 9152379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.
    Dajani EZ; Larsen KR; Taylor J; Dajani NE; Shahwan TG; Neeleman SD; Taylor MS; Dayton MT; Mir GN
    J Pharmacol Exp Ther; 1999 Oct; 291(1):31-8. PubMed ID: 10490883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereochemical requirements for cannabimimetic activity.
    Mechoulam R; Lander N; Srebnik M; Breuer A; Segal M; Feigenbaum JJ; Jarbe TU; Consroe P
    NIDA Res Monogr; 1987; 79():15-30. PubMed ID: 3125475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity.
    Lichtman AH; Smith PB; Martin BR
    Pain; 1992 Oct; 51(1):19-26. PubMed ID: 1454400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of delta 9-THC carbamate.
    Little PJ; Kaplan NC; Martin BR
    Alcohol Drug Res; 1987; 7(5-6):517-23. PubMed ID: 3040025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.